TCTMD

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

BARCELONA, Spain—Among all the big trials airing results at the European Society of Cardiology (ESC) Congress 2017, one tiny stent—and its performance—could have slipped through the cracks. Earlier ...
Medscape

BIOFLOW-V: Orsiro Bests Workhorse Xience at 12 Months

BARCELONA, SPAIN —The biodegradable-polymer Orsiro sirolimus-eluting stent (Biotronik) proved superior to the durable-polymer Xience everolimus-eluting stent (Abbott Vascular) for 12-month target ...
TCTMD

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Final 5-year follow-up from the BIOFLOW V trial continues to show advantages for the ultrathin-strut bioresorbable-polymer Orsiro DES (Biotronik) over the thin-strut, durable-polymer Xience (Abbott), ...